EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND ‐1 Study

Leen Magarbeh iD, Claudia Hassel, Maximilian Choi, Farhana Islam iD, Victoria S Marshe, Clement C Zai, Rayyan Zuberi, Roseann S Gammal iD, Xiaoyu Men, Maike Scherf-Clavel, Dietmar Enko, Benicio N Frey und 19 weitere

Clinical Pharmacology & Therapeutics · 2023

DOI: 10.1002/cpt.2854 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Clinical Pharmacology & Therapeutics, 2023. Verfasst von Leen Magarbeh und 30 weiteren Autor:innen. Beteiligte Einrichtung: Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Major Depressive Disorder. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The P‐glycoprotein efflux pump, encoded by the ABCB1 gene, has been shown to alter concentrations of various antidepressants in the brain. In this study, we conducted a systematic review and meta‐analysis to investigate the association between six ABCB1 single‐nucleotide polymorphisms (SNPs; rs1045642, rs2032582, rs1128503, rs2032583, rs2235015, and rs2235040) and antidepressant treatment outcomes in individuals with major depressive disorder (MDD), including new data from the Canadian Biomarker and Integration Network for Depression (CAN‐BIND‐1) cohort. For the CAN‐BIND‐1 sample, we applied regression models to investigate the association between ABCB1 SNPs and antidepressant treatment response, remission, tolerability, and antidepressant serum levels. For the meta‐analysis, we systematically summarized pharmacogenetic evidence of the association between ABCB1 SNPs and antidepressant treatment outcomes. Studies were included in the meta‐analysis if they investigated at least one ABCB1 SNP in individuals with MDD treated with at least one antidepressant. We did not find a significant association between ABCB1 SNPs and antidepressant treatment outcomes in the CAN‐BIND‐1 sample. A total of 39 studies were included in the systematic review. In the meta‐analysis, we observed a significant association between rs1128503 and treatment response (T vs. C‐allele, odds ratio = 1.30, 95% confidence interval = 1.15–1.48, P value (adjusted) = 0.024, n = 2,526). We did not find associations among the six SNPs and treatment remission nor tolerability. Our findings provide limited evidence for an association between common ABCB1 SNPs and antidepressant outcomes, which do not support the implementation of ABCB1 genotyping to inform antidepressant treatment at this time. Future research, especially on rs1128503, is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderHumansCanadaAntidepressive AgentsATP Binding Cassette Transporter, Subfamily B, Member 1BiomarkersPolymorphism, Single NucleotideGenotypeATP Binding Cassette Transporter, Subfamily B

Substanzen

Antidepressive AgentsATP Binding Cassette Transporter, Subfamily B, Member 1BiomarkersABCB1 protein, humanATP Binding Cassette Transporter, Subfamily B

Autor:innen und Institutionen

  • Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
  • Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Department of Life Sciences, Queen's University, Kingston, Ontario, Canada.
  • Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.
  • Center for Translational and Computational Neuroimmunology, Columbia University Medical Center, New York, New York, USA.
  • Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Leen Magarbeh, Farhana Islam, Roseann S Gammal, Roumen Milev, Raymond W Lam, Stefan Kloiber, Chad A Bousman

Zitieren

APA

Magarbeh, L., Hassel, C., Choi, M., Islam, F., Marshe, V. S., Zai, C. C., Zuberi, R., Gammal, R. S., Men, X., Scherf-Clavel, M., Enko, D., Frey, B. N., Milev, R., Soares, C. N., Parikh, S. V., Placenza, F., Strother, S. C., Hassel, S., Taylor, V. H., …, & Müller, D. J. (2023). ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND ‐1 Study. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.2854

Vancouver

Magarbeh L, Hassel C, Choi M, Islam F, Marshe VS, Zai CC, et al. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND ‐1 Study. Clinical Pharmacology & Therapeutics. 2023. doi:10.1002/cpt.2854

BibTeX
@article{Magarbeh2023,
  author = {Magarbeh, Leen and Hassel, Claudia and Choi, Maximilian and Islam, Farhana and Marshe, Victoria S and Zai, Clement C and Zuberi, Rayyan and Gammal, Roseann S and Men, Xiaoyu and Scherf-Clavel, Maike and Enko, Dietmar and Frey, Benicio N and Milev, Roumen and Soares, Claudio N and Parikh, Sagar V and Placenza, Franca and Strother, Stephen C and Hassel, Stefanie and Taylor, Valerie H and Leri, Francesco and Blier, Pierre and Farzan, Faranak and Lam, Raymond W and Turecki, Gustavo and Foster, Jane A and Rotzinger, Susan and Kloiber, Stefan and Kennedy, James L and Kennedy, Sidney H and Bousman, Chad A and Müller, Daniel J},
  title = {ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta‐Analysis Including Results from the CAN‐BIND ‐1 Study},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  doi = {10.1002/cpt.2854}
}
Kostenlos starten →